-
公开(公告)号:US20220378721A1
公开(公告)日:2022-12-01
申请号:US17771391
申请日:2020-10-22
IPC分类号: A61K31/122 , A61P25/28
摘要: The present disclosure relates to compounds that act as protein kinase inhibitors, especially CK1δ and/or CK1ε inhibitors, which can be used to treat a serine threonine kinase-dependent disease and condition, such as neurodegenerative diseases like Alzheimer's Disease, and the synthesis of the same. Further, the present disclosure teaches the utilization of such compounds in a treatment for neurodegenerative diseases, including Alzheimer's disease.